Calidi Biotherapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2024 | $3.4M | $-14.6M | $1.2M |
| Jun 2024 | $1.9M | $-11.8M | $800.0K |
| Sep 2024 | $2.4M | $-9.8M | $1.9M |
| Dec 2024 | $600.0K | $1.5M | $9.6M |
| Mar 2025 | $600.0K | $6.9M | $10.8M |
| Jun 2025 | $600.0K | $1.8M | $5.4M |
| Sep 2025 | $600.0K | $6.9M | $10.6M |
| Dec 2025 | $600.0K | $3.8M | $5.8M |
| Mar 2026 | $600.0K | $4.9M | $6.9M |
| Jun 2026 | $600.0K | $3.1M | $4.3M |